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Background. A major concern in intervention studies is the generalizability of the findings due to refusal of intended participants
to actually take part. In studies including ill older people the number of those declining to participate may be large and the concern
is therefore relevant. Objectives. To compare patients characteristics, rates of acute readmission, and mortality after one and six
months among older persons who agreed and those who declined to participate in a randomized controlled trial and to describe
subgroups of nonparticipants. Design. Comparative study based on a randomized controlled trial. Setting. University hospital in
the Capital Region of Denmark. Participants. Patients ≥70 years discharged home after a short Emergency Department stay. 399
were requested to participate; 271 consented, whereas 128 refused. Results. Refusers were more likely to be readmitted (𝑝 < 0.001)
or die (𝑝 = 0.006). The largest subgroup of refusers described as “too ill” had the highest risk of readmission (OR = 3.00, 95% CI
= 1.61–5.47, 𝑝 = 0.001) and of mortality within six months (OR = 3.50, 95% CI = 1.64–7.49, 𝑝 = 0.002). However, this seems not
to have affected the results of our randomized study. Conclusion. We recommend that intervention studies among older people or
other fragile patient groups include analysis of relevant risk and subgroup analyses of refusers.
1. Background
The recruitment of participants in intervention studies is
challenging and a major concern is the generalizability of
the findings due to the intended participants’ refusal to
participate (“refusers”). In studies including ill older people
the group of refusersmay be large and the concern is therefore
very relevant [1].
The population of older people does not represent a
uniform group; on the contrary, they form a diversified
group with some being very healthy and fit while others have
multi comorbidities and are in need of daily help to manage
at home. The generalizability of findings from intervention
studies to the wider population of older patients admitted to
Emergency Departments (ED) that exclude such participants
might therefore be limited. In randomized controlled studies,
this is particularly important, as the intervention may have
different effects in different subgroups of the study popula-
tion.
To examine what was reported on older peoples’ refusal
to participate MEDLINE and CINAHL were searched, con-
taining key words “geriatric assessment” or “older peo-
ple” and “emergency department” and “refusers” or “non-
participants.” Of the studies, we found only few had analyses
of differences between refusers and participants or of refuser
subgroups as their main focus. The refusal rates were high
ranging from 12% to 54% [2–9]. Two studies reported no
difference in age [4, 8] and one reported that refusers were
two years younger on average [3]. No difference in gender
was reported by one study [8], whereas two studies reported
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a higher proportion of women among refusers than among
participants [3, 4]. With regard to health, one study reported
that refusers were less likely to be admitted to hospital [3] and
another reported that refusers visited the EDmore frequently
[4].
Concerning risk factors, one study found an increased
risk of entering a nursing home among nonparticipants
[1], whereas another found that nonparticipants had both
a higher mortality rate and a higher rate of nursing home
admission [10]. As these studies involved different methods,
strategies, age groups, and interventions it is not possible
to draw conclusions concerning demographic data or health
about older people in the ED refusing to participate in inter-
vention studies.
Refusers’ reason for not participatingmay help to charac-
terize and understand the group; thus two studies concerning
disability prevention and preventive home visits found that
refusers may be categorized into four groups: “too ill,” “too
healthy,” “not interested,” and “other reasons” [1, 10]. Both
found that the subgroup of refusers describing themselves
as “too ill” had a significantly higher rate of mortality than
participants. A qualitative study examining attitudes and
views among community-dwelling older people at risk of
falling who either rejected referral to or completed a hospital-
based falls clinic assessment program found that the two
groups expressed opposite opinions regarding most topics;
for example, all of the refusers thought that nothing could
be done about their falls problem, while all of the accepters
thought that something could be done [11].
We found only one intervention study involving older
people in EDs that reported reasons for refusal and then only
in 25%of the cases.The reasons givenwere being too ill, being
unable to consent, leaving before the completion of tests, and
being given medications that could affect patients’ mental
status during testing [9].
In Denmark 30% of those who use the ED are aged
70 and above [12]. Because of preexisting and complex
problems, geriatric assessment and intervention are often
required. Though patients may stay for 3 days this is usually
not provided and studies have shown that up to 80% of
geriatric patients discharged from ED have at least one
unrecognized geriatric problem [13, 14]. The proportion of
patients declining to participate could bemore than one-third
of those invited [1, 10].Thus our aim was to compare baseline
data, rates of readmission to hospital, and mortality rates
among older persons who accepted and those who declined
to participate in a randomized controlled trial and to describe
the subgroups of nonparticipants.
2. Material and Methods
2.1. The Randomized Controlled Trial. The study was
designed as a prospective controlled, randomized follow-up
study with intervention to evaluate the effect of a short, two-
stage nursing assessment and intervention. The intervention
was the Standardized Evaluation and Intervention for
Seniors At Risk (SEISAR) and comprised a problem-
identifying assessment and a problem solving intervention
[6]. The assessment consists of a brief, standardized nursing
assessment with a checklist of 10 items. Following the assess-
ment, a plan was made to resolve the problems together
with the older person. Both the intervention and the control
group received visits from the hospitals geriatric nurses
where several functional assessment scales were performed.
The trial was registered with Current Controlled Trials
Ltd. and the International Standard Randomized Controlled
Trial Number (ISRCTN) is ISRCTN08788893. Study design
and results have been published elsewhere [15].
2.2. Participants. The setting was the ED of a 150-bed
University Hospital in the Capital Region of Denmark. The
population of the catchment areawas 160,000. FromFebruary
2009 to February 2011 we included patients aged 70 and above
at increased risk of readmission and functional decline and
patients who were discharged to their own homewithin three
days. All patients admitted to the ED aged 70 and above were
screened using the ISAR screen [16] and considered to be
at an increased risk of readmission and functional decline
if their score was 2–6. Research nurses in the ED selected
patients, however; if patients were not contacted before
discharge the nurses phoned them and arranged a visit within
three days of discharge. Unlike most intervention studies
concerning older people, we did not exclude those suffering
from cognitive impairment as they represent approximately
one out of four and we hypothesized that they might very
well benefit from the intervention. Patients were excluded
if they were admitted from a nursing home, were unable to
communicate in Danish, were nonresidents of the catchment
area, or suffered from terminal cancer.
2.3. Enrolment. When high-risk patients (i.e., those with an
ISAR score of two or more) were identified and agreed to
participate, they were randomly assigned following a simple
randomization procedure (computerized random numbers)
to either the intervention or control group.
The enrolment of the study population is described in
detail in Figure 1. If the patient declined to participate the
main reasons for refusal were registered and categorized into
four groups: “too ill,” “too healthy,” “not interested,” or “gave
no reason.”
2.4. Measures Outcome. Individuals who were eligible to
participate in the study were classified with regard to their
status as participants or nonparticipants (i.e., those who
actively said no). Sex, age, marital status, medical problems,
medication, acute readmission to hospital (admission to
hospital not including planned admission such as elective
surgery or treatment) within one and six months, and
mortality were recorded from the hospital’s administrative
database.
2.5. Analyses. Baseline data was described using mean and
observed frequencies. Participants and refusers were com-
pared by chi-square test for categorical variables and by two-
sample 𝑡-test for continuous variables. Whereas more than
20% of the cells had expected counts under five, Fisher’s exact
test was used. To compare the differences between groups
from baseline to follow-up in readmission to hospital and
Scientifica 3
148 patients scored ISAR
0-1
271 underwent
randomisation
103 residents of nursing
homes
864 lived outside
catchment area
26 unable to communicate
in Danish
1098
547
1962 patients ≥ 70 years were discharged home from ED within 3 days
399 patients scored ISAR ≥2
128 did not provide consent 
55 stated they were too ill
5 stated they were too well
55 gave no reason
13 stated they were not 
interested in visits to their
home
422 not contacted due to the following:
(i)
out of order for two days during
recruitment period
(ii)
(iii)
Hospital administrative database
No telephone number available
Being terminally ill
Figure 1: Enrolment of the study population.
death, logistic regression analyses were used. 𝑝 values under
0.05 were considered significant. All statistical tests were
performed using SAS, version 9.0.
2.6. Ethics. The ethical principles of the Helsinki Declaration
[17] were followed. All participants were given both written
and verbal information about the study and they gave written
consent if capable of doing so; for confused or demented
participants, proxy consents were obtained. No proxy was
contacted without the participant’s consent. Patients who
declined to participatewere asked to give consent to their data
being used. The study has been approved by the Danish Data
Protection Agency (j.nr.2008-41-2768).
This study was supported by TrygFonden and Lundbeck
Foundation in Denmark as well as University of Southern
Denmark. The funding sources had no role in the study
design, data collection, analyses or interpreting data, writing
the report, or the decision to submit the paper for publication.
3. Results
During the recruitment period, a total of 1,962 patients aged
70 and above were admitted to the ED and discharged within
three days. Of these, 547 were screened with ISAR and 399
scored 2 or more and therefore were considered at increased
risk of functional decline and readmission (Figure 1). These
patients were invited to participate in the study. Two hun-
dred seventy-one patients agreed to participate, whereas 128
refused (32%).Themean age for participants was 81 years and
82 for refusers. No baseline differences were found concern-
ing age, gender, or marital status between participants and
refusers (Table 1). The allocation within the ISAR score was
equal in both groups and we found no differences in baseline
medical problems (Table 1). Significantly more refusers were
readmitted to hospital at six months after the initial ED visit
(𝑝 < 0.001). Death rates within periods of both one and
six months were significantly higher among refusers (resp.,
𝑝 = 0.02 and 𝑝 = 0.006) than of participants (Table 2).
3.1. Comparison Involving Subgroups of Refusers. Of all
refusers, 43% described themselves as “too ill,” 10% as “not
interested, and ” 4% as “too healthy” and 43% gave no reason.
In the subgroup analyses, we found more women in the
nonparticipating subgroup of “too healthy” and “not inter-
ested” than in the participating group (Table 1). There were
significantly more married people in the nonparticipating
subgroup of “too healthy” than in the participating group. No
married people were found in the group “not interested”; we
found no significant differences in age. At baseline we found
a difference in allocation with patients at risk of readmission
and functional decline measured by the ISAR score as among
refusers who were “too healthy” or “not interested” no one
had a high ISAR score of 4–6 (worst score), while among
participants 23% had an ISAR score of 4–6 (Table 1).
During the six-month follow-up the groups who
described themselves as “too ill and “not interested” and
who “gave no reason” had a significantly higher rate of
readmission compared to participants. Moreover, refusers
who described themselves as “too ill” were more likely to
have been prescribed more than three different medications
(𝑝 = 0.05), theywere significantlymore at risk of readmission
within one (OR = 2.10, 95% CI = 1.07–4.15, 𝑝 = 0.03) and six
months (OR = 3.00, 95% CI = 1.61–5.47, 𝑝 = 0.001), and their
mortality rate was higher within six months (OR = 3.50, 95%
CI = 1.64–7.49, 𝑝 = 0.002).
4. Discussion
The focus of this study was to describe the subgroups of
nonparticipants and to compare baseline data, as well as rates
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Table 1: Baseline characteristics of participants, refusers, and subgroups of refusers.
Invited to participate, 𝑛 = 399
Participants, 𝑛 (%) Refusers, 𝑛 (%)
Total participants Total refusers 𝑝 Too healthy 𝑝 Too ill 𝑝 Not interested 𝑝 No reason 𝑝
271 (68) 128 (32) 5 (4) 55 (43) 13 (10) 55 (43)
Age, mean (SD) 82 (6.6) 81 (7.0) 85 (8.7) 0.39 80 (6.5) 0.10 81 (6.4) 0.67 82 (7.4) 0.98
Female 180 (66) 77 (60) 0.22 1 (20) 0.05∗ 33 (60) 0.37 11 (85) 0.23∗ 11 (58) 0.25
Married 61 (23) 26 (24) 0.70 3 (60) 0.08∗ 15 (32) 0.17 0 0.13∗ 8 (18) 0.47
Medical problems 0.59∗ 0.25∗ 0.98∗ 0.23∗
Neurological 18 (7) 1 (20) 2 (4) 0 4 (7)
Cardiovascular 36 (13) 0 7 (13) 1 (8) 8 (15)
Respiratory 18 (7) 0 9 (16) 1 (8) 4 (7)
Musculoskeletal 24 (9) 0 2 (4) 1 (8) 2 (4)
Infectious 32 (12) 1 (20) 6 (11) 2 (15) 13 (24)
Other categories 143 (53) 3 (60) 29 (53) 8 (61) 24 (43)
ISAR I score 0.91 0.29∗ 0.18 0.06∗ 0.43
2 100 (37) 40 (37) 1 (20) 12 (22) 7 (54) 20 (36)
3 109 (40) 46 (42) 4 (80) 19 (35) 3 (23) 20 (36)
4–6 62 (23) 23 (21) 0 16 (29) 0 7 (13)
Medication prescribed > 3 237 (92) 96 (93) 0.66 5 (100) 1.00∗ 42 (100) 0.05∗ 6 (75) 0.15∗ 43 (90) 0.58∗
∗Fisher’s exact test.
of readmission to hospital and mortality among those who
agreed and thosewho declined to participate in a randomized
controlled trial with follow-up home visits. No baseline
differences were found when comparing participants and
refusers but we found a significant difference in death rates
within periods of both one and six months among refusers
(resp., 𝑝 = 0.02 and 𝑝 = 0.006), compared to participants.
This indicates that baseline comparisons among participants
and refusers are not adequate to indicate if there is a difference
between the groups; comparison on follow-up data must also
be carried out. We also found that refusers who described
themselves as “too ill” and “not interested” and who “gave
no reason” had a significantly higher rate of readmission
compared to participants and that refusers described as “too
ill” were significantly more at risk of readmission within one
(OR = 2.10, 95%CI = 1.07–4.15,𝑝 = 0.03) and sixmonths (OR
= 3.00, 95%CI = 1.61–5.47, 𝑝 = 0.001) and their mortality rate
was higher within sixmonths (OR = 3.50, 95%CI = 1.64–7.49,
𝑝 = 0.002). This indicates that not only must the baseline
comparison be extended with analyses of follow-up data, but
also subgroup analyses among different groups of refusers
should be performed.
Because there were no differences between the aggregated
groups scores for refusers and participants in terms of demo-
graphic data, distribution of ISAR score, data concerning
medication, or ED visits prior to initial ED admittance
at baseline, the finding of differences in readmission and
mortality rates was unexpected.
During the six-month follow-up, the refusers experienced
a significantly higher rate of readmission to hospital and
mortality compared to participants. The study inclusion and
exclusion criteria may have influenced the study outcome
as well as the distribution of refusers. By not excluding
patients with dementia, 41% of our study population were
cognitively impaired [15]. ED based interventions in those
with dementia have not so far proved effective, as Shaw et
al. found no significant difference between intervention and
control groups in proportion of those who fell during one
year’s follow-up [18]; therefore having such a large group of
participants with cognitive impairmentmight haveweakened
our results. In addition, we excluded those living in a nursing
home and as studies imply that they might benefit from
multidisciplinary interventions in the ED [19], including
those patients may further have influenced our results.
As the difference in readmission and mortality was
particularly clear in the subgroup of refusers who described
themselves as “too ill” to participate, the finding triggered
us to perform a subgroup analysis by reasons for refusing
to participate. Other studies found that refusers are disabled
at baseline [4, 20, 21] and have a higher risk of mortality
[1, 10, 21] which supports our findings. The refusers who
described themselves as “too ill” represented 43% of all the
refusers in our study and thus weighted more heavily in the
analyses of the total group of refusers.
We found no other intervention studies conducted in
ED that both included older people and contained analyses
of the subgroups of refusers. However, it seems that four
subgroups exist, as defined by their reasons for refusal, “too
healthy,” “too ill,” and “not interested” and the ones who gave
“no reason.” Two randomized trials on disability prevention
describe similar subgroups as being “too healthy,” “too ill,”
and “not interested,” and giving “no reason” [1, 10]; only the
subgroup whosemembers defined themselves as “too ill” was
larger in our study than in these trials (43% versus 12%).This
may be explained by our trial including older people who had
just been hospitalized and who were at risk of readmission
Scientifica 5
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and functional decline, whereas the other studies included
older people at home.
The refusers who were “too healthy” were a small group
in our study and had a lower risk of readmission or death
than the other subgroups. As the targeted group in our
intervention study was older people with an ISAR score
≥2, it is only to be expected that the “too healthy” group
was relatively small [15]. The largest subgroup of refusers
consisted of those who stated they were “too ill” and those
giving no reason for refusal. Those declaring themselves to
be “too ill” had the highest risk of readmission and death
and it seems likely that they had an accurate perception of
their own health when describing themselves as “too ill” to
participate. The expression “too ill” could also mean that
the older people cannot manage extra home visits because
they already have professionals coming from the community
services assistance during the day. The subgroup that stated
theywere “not interested” consisted ofmorewomen andnone
of them were married.They had a greater risk of readmission
after 6 months compared to the participants and it is well
known that living alone itself appears to be associated with
a higher risk of falling and constellations of pathologies [22].
The subgroup that gave no reason also had a higher risk of
readmission and death compared to the participants. As they
gave no reason we do not know why they did not want to
participate but, as described by Reuben et al. [23], it may be
that the perceived benefit was too low.
A different distribution of refuser subgroups in the
studies examining geriatric assessment and intervention may
have influenced the results of earlier studies as it seems that
overall differences in health status can be hidden if only
aggregated analyses of the refusers are carried out. As we
do not know if the subgroups in other studies reflect similar
dimensions as in ours we may not be able to compare results
and this may very well be part of an explanation as to why our
results differ.
It is unlikely that the findings of the subgroup analyses
would have had implications for the conclusion of our
intervention study [15]. Members of the subgroup describing
themselves as “too ill” represented 43% of the refusers and
they had a higher risk of readmission to hospital or death.
As results from our intervention study showed that the
participants with an ISAR score of ≥2 had no effect on
primary outcomes of the intervention [15], including the
refusers may just have strengthened our results.
4.1. Limitations. We included participants that stayed
between one and three days in the ED and considered this
a short stay. We are aware that in some countries a short
ED stay is less than 24 hours. In spite of this difference, our
results may still be relevant as common to the EDs are that
staff qualifications and the treatment are focused on acute
care. Another limitation is that 43% of the refusers did not
give a reason for refusal. This may be due to the research
nurses not being persistent enough when asking for a reason.
We do not know whether the subgroup analyses might have
given another result if more had answered.
In general, as with all randomized controlled trial sub-
group analysis the inference can only be hypothetical and
possible pointer to further investigation and future study
design. It does not weaken the negative findings of our
published study, pointing instead to the possible need for a
different intervention with perhaps different subject selection
criteria in a future study.
5. Conclusion
In conclusion, when only simple aggregated analyses of
refusers’ baseline data were carried out we noticed no dif-
ferences either in participants compared to refusers or in the
subgroups of refusers.
In order to reveal differences in participants and refusers
we thus recommend that intervention studies concerning
older people include analyses of follow-up data as well as
subgroup analyses of refusers.
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